Supernus Pharmaceuticals, Inc. (SUPN)
50.80
+0.59
(+1.18%)
USD |
NASDAQ |
Mar 17, 16:00
50.80
0.00 (0.00%)
After-Hours: 16:38
Supernus Pharmaceuticals Market Cap : 2.925B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.19B |
| BridgeBio Pharma, Inc. | 13.75B |
| Corcept Therapeutics, Inc. | 3.565B |
| Catalyst Pharmaceuticals, Inc. | 2.850B |
| Cytokinetics, Inc. | 7.655B |
Market Cap Related Metrics
| PS Ratio | 3.999 |
| Price to Book Value | 2.755 |
| Price to Free Cash Flow | 62.52 |
| Price | 50.80 |
| Earnings Yield | -1.35% |